Pharmaceutical Group Sales And Collection Cycle Internal Control Case Analysis

China state-owned enterprises determines the lifeline of China’s economy, the riseand fall of state-owned enterprises basically determines our economy healthy andsustainable development of the traditional concept, but we decided that our managementof state-owned enterprises, more extensive, so the countrynot to standardize themanagement regulation of state-owned enterprises,composed of five ministries issued thebasic norms of internal. Control of theseries and its supporting guidelines, as animportant part of state-owned enterprises, state-owned pharmaceutical enterprises whenone of the first to become the internal control standard guide object.As Chinese pharmaceutical industry leading enterprises, Xinhua PharmaceuticalGroup after decades of rapid development, formed a more suitable for theirownmanagement system, but with the continuous improvement of enterprise salesand thecontinuous growth of enterprises, enterprises also emerged some new problems, such ascredit management, management of risk, the development of enterprises increasinglyrestricted by these factors, now these problems have been put on the table, or root causesof Xinhua Pharmaceutical Group sales and collection cycle internal control is not suitablefor the current development of the enterprise, become a stumbling block to the furtherdevelopment of enterprises.This article is based on the actual Xinhua Pharmaceutical Group, through carefulanalysis of its presence in the sale and collection cycle problem, finding a feasible way. Acase study in this paper can provide a guideline for thepharmaceutical enterprises inchina.This paper is elaborated in the following sections:The first part is the introduction, mainly studies the research background of internalcontrol theory, meaning and purpose of research.The second part begins to internal control summary Xinhua Pharmaceutical Groupsales and collection cycle, mainly about the current situation of internal control ofXinhua Pharmaceutical Group background of its own.The third part is within the group are control environment, risk, controlactivities,communication and internal supervision problem on the line analysis. The fourth part puts forward several reasons: management sales underestimaterisk,risk management is misplaced, a fully fit inside their own information systemsis notfound, the lack of implementation of the supervision department.The fifth part is the concrete measures are put forward according to the third part ofthe five elements of COSO framework, such as the perfection of human resources system,the enterprise’s goal setting, the integration of enterprisemarketing management systemand financial management system.